Fludarabine-cyclophosphamide-based conditioning with antithymocyte globulin serotherapy is associated with durable engraftment and manageable infections in children with severe aplastic anemia

HIGHLIGHTS

• who: Małgorzata Salamonowicz-Bodzioch et al. from the Department of Pediatric Oncology, Haematology and Bone Marrow Transplantation, Department of Oncology, Hematolgy and Transplantology, University Hospital USK in Wroclaw have published the paper: Fludarabine-Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia, in the Journal: (JOURNAL)
• what: The aim of this study was to evaluate the introduce a combination of fludarabine, cyclophosphamide and antithymocyte globulin outcome of a conditioning protocol, FluCyATG, in children undergoing transplantation (FluCyATG).
• how: Because no patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.